Characterisation of lisdexamfetamine dimesylate use in children, adolescents and adults in Europe

被引：0
|
作者：
Siffel, C. [1 ]
Page, M. [1 ]
Maxwell, T. [1 ]
Thun, B. [2 ]
Kolb, N. [2 ]
Ehlken, B. [2 ]
Rosenlund, M. [3 ]
Von Bredow, D. [2 ]
Keja, J. [4 ]
机构：
[1] Shire, Lexington, MA USA
[2] IQVIA, Hlth Econ & Outcomes Res, Munich, Germany
[3] IQVIA, Hlth Econ & Outcomes Res, Solna, Sweden
[4] IQVIA, Hlth Econ & Outcomes Res, Paris, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.692
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.828
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Zuddas, A.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C.
    Yan, B.
    Caballero, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648
  • [32] Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Childress, Ann C.
    Cutler, Andrew J.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (04): : 395 - 405
  • [33] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Rakesh Jain
    Thomas Babcock
    Teodor Burtea
    Bryan Dirks
    Ben Adeyi
    Brian Scheckner
    Robert Lasser
    John Renna
    Don Duncan
    Advances in Therapy, 2013, 30 : 472 - 486
  • [34] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [35] Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Findling, Robert L.
    Wu, James
    Kollins, Scott H.
    Wang, Yi
    Martin, Patrick
    Robertson, Brigitte
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (03) : 128 - 136
  • [36] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [37] Lisdexamfetamine dimesylate (LDX) in children with ADHD after suboptimal response to methylphenidate
    Jain, R.
    Duncan, D.
    Babcock, T.
    Burtea, T.
    Dirks, B.
    Adeyi, B.
    Shaw, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S126 - S127
  • [38] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Jain, Rakesh
    Babcock, Thomas
    Burtea, Teodor
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    Lasser, Robert
    Renna, John
    Duncan, Don
    ADVANCES IN THERAPY, 2013, 30 (05) : 472 - 486
  • [39] Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
    Wigal, Timothy
    Brams, Matthew
    Gasior, Maria
    Gao, Joseph
    Giblin, John
    POSTGRADUATE MEDICINE, 2011, 123 (02) : 169 - 176
  • [40] Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD
    Adler, Lenard A.
    Lynch, Lauren R.
    Shaw, David M.
    Wallace, Samantha P.
    O'Donnell, Katherine E.
    Ciranni, Michael A.
    Briggie, Alexis M.
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (02) : 149 - 157
12345